2Guo-Ping Jiang, Zhen-Hua Hu, Shu-Sen Zheng, Chang-Ku Jia, Ai-Bin Zhang, Wei-Lin Wang, Department of Hepatobiliary Pancreatic Surgery, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China.Adenovirus-mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation[J].World Journal of Gastroenterology,2005,11(7):1065-1069. 被引量：14
5Kreitman RJ. Immunotoxins for targeted cancer therapy[ J]. AAPS J, 2006, 18(3) :532 -551. 被引量：1
6Piascik P. FDA approves fusion protein for treatment of lymphoma[J].J Am Pharm Assoc, 1999, 39(4) :571 - 572. 被引量：1
7Mathew M, Verma RS. Humanized immunotoxins : a new generation of immunotoxins for targeted cancer therapy [ J ]. Cancer Sci, 2009, 100(8) :1359 - 1365. 被引量：1
8Aqeilan R, Yarkoni S, Eorberboum-Galski H. Interleukin 2 Bax: a novel prototype of human chimeric proteins for targeted therapy [J]. FEBS Lett, 1999, 457(2) :271 -276. 被引量：1
9Azar Y, Lorberboum-Galski H. GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells: the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing compo- nents of targeting chimeric proteins[ J]. Apoptosis, 2000, 5 (6) : 531 - 542. 被引量：1
10Lafevre-Bemt M, Wu S, Lin X. Recombinant,refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptocis in p53-deficient cancer cells [ J ]. Mot Cancer Ther, 2008, 7 (6) : 1420 - 1429. 被引量：1
